Introduction: Cardiovascular complications represent the leading cause of morbidity and mortality in patients with Marfan syndrome. Here, we describe a unique case where a total artificial heart was implanted in a young Marfan syndrome woman. Methods: A 22-year-old postpartum African American female with Marfan syndrome developed multiple severe valve dysfunction and biventricular failure that was refractory to medical management. She previously had a Bentall procedure for Type A aortic dissection and repair of a Type B dissection. Results: We implanted a total artificial heart with a good outcome. Conclusion: Total artificial heart is a durable option for severe biventricular failure and multiple valvular dysfunction as a bridge to transplant in a young patient with Marfan syndrome.
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Background
Cardiovascular complications represent the leading cause of morbidity and mortality in patients with Marfan syndrome (MFS). Women with MFS have an increased risk of accelerated aortic dilation and rupture in pregnancy. 1 Other cardiac complications associated with MFS include aortic aneurysms, mitral valve disease, aortic valve insufficiency (AI), arrhythmias, and cardiomyopathy. Here, we describe a unique case of implanting a total artificial heart (TAH; Syncardia ™ , Tucson, AZ, USA) in a patient with MFS.
Case presentation
A 22-year-old African American female with MFS presented to the emergency department with 1 week of congestive symptoms consistent with heart failure. Following the birth of her first child 10 months previously, she had developed a Type A aortic dissection and severe AI that was repaired with a Bentall procedure using a Gelweave Valsalva ™ aortic root graft (Vascutek ™ , Inchinnan, Scotland) and a 25-mm Edwards pericardial tissue valve. She then developed a Type B dissection requiring repair with a 20-mm Hemashield tube graft (MAQUET ™ , Rastatt, Germany) as well as cardiac arrest secondary to ventricular tachycardia with subsequent ejection fraction (EF) of 10%-15% requiring an implantable cardioverterdefibrillator. On this hospital admission, she became hypotensive and was started on norepinephrine and dobutamine for decompensated biventricular heart failure. However, 10 days later, she was inotrope dependent and had refractory liver congestion not responsive to diuresis. Echocardiography showed severe biventricular dilation
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The International Journal of Artificial Organs 41 (3) with a left ventricular end-diastolic dimension (LVEDD) of 92 mm, EF of 10%-15%, severely reduced right ventricular function, a severely dilated right atrium, and severe mitral and tricuspid regurgitations. Right heart catheterization while on milrinone showed elevated left and right heart filling pressures and mild pulmonary hypertension (pulmonary artery pressure 40/28 mmHg, pulmonary capillary wedge pressure 24 mmHg, and pulmonary vascular resistance 1.47 Wood units). Given that she was a good transplant candidate with severe valve incompetence and biventricular failure and had a previous median sternotomy, a TAH was preferred over implanting a left ventricular assist device (LVAD) with a temporary right ventricular assist device (RVAD). In addition, she had a high panel-reactive antibodies (PRA; Class I: 96% and Class II: 17%), so it was felt that a durable biventricular device was best option as a bridge to transplant. Based on the fit test, we knew that a 70cc TAH (Figure 1 ) would be appropriate.
Treatment
We performed a re-do median sternotomy, initiated cardiopulmonary bypass, and crossclamped the aorta. We proceeded to a partial cardiectomy and fashioned atrial cuffs 3 mm below the mitral and tricuspid valves. After opening the aortic root, we explanted the old bioprosthetic valve and sewed the inflow and outflow grafts of the TAH to the left atrium, right atrium, pulmonary artery, and aorta, respectively. The aortic outflow graft was beveled and sewn to the Dacron graft of the prior Bentall conduit in the ascending aorta ( Figure 2) . We covered the TAH with an expanded polytetrafluoroethylene membrane. The overall bypass and cross clamp times were 241 and 209 min, respectively.
Outcome and follow-up
On post-operative day (POD) 1, she developed tonicclonic seizures. She was diagnosed with status epilepticus and loaded with phenytoin, lacosamide, and levetiracetam. A computed tomography (CT) head demonstrated an evolving posterior temporal lobe infarct, which was due to de-airing of the TAH. Seizures were controlled by POD 8. On POD 10, she developed low filling pressures, elevated central venous pressure (CVP), and increasing pressor requirement. A half-liter of serosanguinous fluid was collected in the right chest tube over 45 min, and the patient became severely acidotic, with hemoglobin of 3.5 µ/L. We performed a repeat median sternotomy and found her in tamponade from a mediastinal hematoma. The source of bleeding was found to be a branch of the right coronary artery in the ventricular muscle which was promptly ligated. Following this, her CVP, flow rates, lactate, and systolic blood pressure all improved.
The patient's neurological status also improved, and she was able to ambulate with physical therapy by POD 31 and was discharged home on POD 60. She is doing well 1 year post-implant and awaiting a heart on the transplant list.
Discussion and conclusion
Aortic root dilatation with AI and aortic dissection often precedes multiple valvular disease presentations in MFS patients. Concomitant with AI, mitral, and tricuspid regurgitations are often observed in MFS patients. 2 Orthotopic heart transplantation (OHT) in MFS patients results in good long-term survival similar to those without MFS. 3 Aortic rupture following OHT is a common complication, and some surgeons advocate aggressive treatment with complete aortic arch replacement during OHT. Our patient had an ascending and descending aortic repair before; therefore, further aortic intervention was not necessary. Due to the scarcity of organs, OHT is not always possible. A single report shows successful LVAD placement as a bridge to transplant in an MFS patient. 4 Here, we report successful TAH implantation in a patient with MFS. We believe this is a good, durable option in the setting of severe, refractory biventricular congestive heart failure (CHF) and multiple valvular dysfunction as a bridge to transplant in a young patient.
